LCM
BNTX icon

Laurion Capital Management’s BioNTech BNTX Stock Holding History

Laurion Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-16,359
Closed -$2.79M – 496
2022
Q1 		$2.79M Hold
16,359
– – 0.03% 194
2021
Q4 		$4.22M Hold
16,359
– – 0.04% 208
2021
Q3 		$4.47M Hold
16,359
– – 0.02% 355
2021
Q2 		$3.66M Sell
16,359
-3,810
-19% -$719K 0.02% 309
2021
Q1 		$2.2M Buy
20,169
+680
+3% +$72.2K 0.01% 418
2020
Q4 		$1.59M Sell
19,489
-680
-3% -$66.8K 0.01% 361
2020
Q3 		$1.4M Hold
20,169
– – 0.02% 360
2020
Q2 		$1.35M Hold
20,169
– – 0.02% 366
2020
Q1 		$1.18M Sell
20,169
-118,031
-85% -$4.59M 0.01% 443
2019
Q4 		$4.68M Buy
+138,200
New +$3.1M 0.04% 313

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Laurion Capital Management's BNTX Position: Q2 2022 in Review

Laurion Capital Management sold out of BioNTech (BNTX) in Q2 2022, closing a stake of 16,359 shares — an estimated $2.79M sold.

Laurion Capital Management first reported a position in BNTX in Q4 2019 and held it in 10 quarters. The position peaked at $4.68M in Q4 2019. 293 funds tracked by Wall St. Rank hold BNTX as of Q2 2022.

  • Laurion Capital Management reported no remaining BioNTech position as of Q2 2022 after selling out during the quarter.
  • Laurion Capital Management sold 16,359 BioNTech shares in Q2 2022, an estimated $2.79M.
  • Laurion Capital Management first reported a position in BioNTech in Q4 2019 and held it in 10 quarters.
  • Laurion Capital Management's BioNTech position peaked at $4.68M in Q4 2019.
  • 293 funds tracked by Wall St. Rank held BioNTech as of Q2 2022.

Based on Laurion Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.